# Circle Internet Group, Inc.: financial statements, quarterly

CRCL · NYSE · CIK 1876042 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crcl.md) · [Financials](/companies/crcl/financials.md) · [Filings](/companies/crcl/filings.md) · [Insiders](/companies/crcl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crcl/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [6.8](/filings/0001628280-25-039781.md) | [0.5](/filings/0001876042-25-000047.md) | [2.4 d](/filings/0001876042-26-000062.md) | [20.7](/filings/0001876042-26-000150.md) | [23.8](/filings/0001876042-26-000248.md) | [28.5](/filings/0001876042-25-000047.md) | [36.8 d](/filings/0001876042-26-000062.md) | [41.6](/filings/0001876042-26-000150.md) | [33.6](/filings/0001876042-26-000248.md) |
| Operating income | $m | not reported | [50.2](/filings/0001628280-25-039781.md) | [63.8](/filings/0001876042-25-000047.md) | [0.8 d](/filings/0001876042-26-000062.md) | [92.9](/filings/0001876042-26-000150.md) | [(326)](/filings/0001876042-26-000248.md) | [81.0](/filings/0001876042-25-000047.md) | [55.2 d](/filings/0001876042-26-000062.md) | [45.0](/filings/0001876042-26-000150.md) | [34.4](/filings/0001876042-26-000248.md) |
| Interest expense | $m | not reported | [0.5](/filings/0001628280-25-039781.md) | [0.5](/filings/0001876042-25-000047.md) | [0.4 d](/filings/0001876042-26-000062.md) | [0.3](/filings/0001876042-26-000150.md) | [0.3](/filings/0001876042-26-000248.md) | [0.4](/filings/0001876042-25-000047.md) | [0.2 d](/filings/0001876042-26-000062.md) | [0.0](/filings/0001876042-26-000150.md) | [0.1](/filings/0001876042-26-000248.md) |
| Income tax | $m | not reported | [19.2](/filings/0001628280-25-039781.md) | [15.2](/filings/0001876042-25-000047.md) | [5.9 d](/filings/0001876042-26-000062.md) | [25.0](/filings/0001876042-26-000150.md) | [(3.9)](/filings/0001876042-26-000248.md) | [(61.3)](/filings/0001876042-25-000047.md) | [6.8 d](/filings/0001876042-26-000062.md) | [1.4](/filings/0001876042-26-000150.md) | [4.1](/filings/0001876042-26-000248.md) |
| Net income | $m | [48.6](/filings/0001876042-25-000047.md) | [32.9](/filings/0001876042-25-000047.md) | [71.0](/filings/0001876042-25-000047.md) | [3.1 d](/filings/0001876042-26-000062.md) | [64.8](/filings/0001876042-26-000150.md) | [(482)](/filings/0001876042-26-000248.md) | [214](/filings/0001876042-25-000047.md) | [133 d](/filings/0001876042-26-000062.md) | [55.3](/filings/0001876042-26-000150.md) | [48.2](/filings/0001876042-26-000248.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0001628280-25-039781.md) | [0.00](/filings/0001876042-25-000047.md) | not reported | [0.00](/filings/0001876042-26-000150.md) | [(4.48)](/filings/0001876042-26-000248.md) | [0.64](/filings/0001876042-25-000047.md) | not reported | [0.21](/filings/0001876042-26-000150.md) | [0.18](/filings/0001876042-26-000248.md) |
| Basic EPS | $ per share | not reported | [0.00](/filings/0001628280-25-039781.md) | [0.00](/filings/0001876042-25-000047.md) | not reported | [0.00](/filings/0001876042-26-000150.md) | [(4.48)](/filings/0001876042-26-000248.md) | [0.93](/filings/0001876042-25-000047.md) | not reported | [0.23](/filings/0001876042-26-000150.md) | [0.19](/filings/0001876042-26-000248.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [0.4](/filings/0001876042-26-000062.md) | not reported | [0.5](/filings/0001628280-25-039781.md) | [0.6](/filings/0001876042-25-000047.md) | [0.8](/filings/0001876042-26-000062.md) | [0.8](/filings/0001876042-26-000150.md) | [1.1](/filings/0001876042-26-000248.md) | [1.3](/filings/0001876042-25-000047.md) | [1.5](/filings/0001876042-26-000248.md) | [1.5](/filings/0001876042-26-000150.md) | [1.7](/filings/0001876042-26-000248.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | [45.2](/filings/0001876042-26-000062.md) | not reported | [63.3](/filings/0001628280-25-039781.md) | [75.9](/filings/0001876042-25-000047.md) | [77.8](/filings/0001876042-26-000248.md) | [79.6](/filings/0001876042-26-000150.md) | [76.2](/filings/0001876042-26-000248.md) |
| Total assets | $bn | not reported | not reported | not reported | not reported | not reported | [45.8](/filings/0001876042-26-000062.md) | not reported | [64.2](/filings/0001628280-25-039781.md) | [76.8](/filings/0001876042-25-000047.md) | [78.7](/filings/0001876042-26-000248.md) | [80.5](/filings/0001876042-26-000150.md) | [77.2](/filings/0001876042-26-000248.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [44.0](/filings/0001876042-26-000062.md) | not reported | [61.7](/filings/0001628280-25-039781.md) | [73.7](/filings/0001876042-25-000047.md) | [75.3](/filings/0001876042-26-000248.md) | [77.1](/filings/0001876042-26-000150.md) | [73.6](/filings/0001876042-26-000248.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [44.1](/filings/0001876042-26-000062.md) | not reported | [61.8](/filings/0001628280-25-039781.md) | [73.8](/filings/0001876042-25-000047.md) | [75.4](/filings/0001876042-26-000248.md) | [77.1](/filings/0001876042-26-000150.md) | [73.7](/filings/0001876042-26-000248.md) |
| Shareholders' equity | $bn | [(0.3)](/filings/0001876042-26-000062.md) | [0.3](/filings/0001876042-25-000047.md) | [0.4](/filings/0001876042-25-000047.md) | [0.5](/filings/0001876042-25-000047.md) | [0.6](/filings/0001876042-25-000047.md) | [0.6](/filings/0001876042-26-000062.md) | [0.7](/filings/0001876042-25-000047.md) | [2.4](/filings/0001876042-25-000047.md) | [3.0](/filings/0001876042-25-000047.md) | [3.3](/filings/0001876042-26-000248.md) | [3.4](/filings/0001876042-26-000150.md) | [3.5](/filings/0001876042-26-000248.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [113 d](/filings/0001876042-25-000047.md) | [106 d](/filings/0001876042-26-000062.md) | [56.6](/filings/0001876042-26-000150.md) | [247 d](/filings/0001876042-26-000248.md) | [(10.7) d](/filings/0001876042-25-000047.md) | [249 d](/filings/0001876042-26-000062.md) | [21.1](/filings/0001876042-26-000150.md) | [517 d](/filings/0001876042-26-000248.md) |
| Capital expenditure | $m | [5.6 d](/filings/0001876042-25-000047.md) | [9.2 d](/filings/0001876042-26-000062.md) | [5.9](/filings/0001876042-26-000150.md) | [1.6 d](/filings/0001876042-26-000248.md) | [4.1 d](/filings/0001876042-25-000047.md) | [1.0 d](/filings/0001876042-26-000062.md) | [9.4](/filings/0001876042-26-000150.md) | [1.0 d](/filings/0001876042-26-000248.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [70.4](/filings/0001628280-25-039781.md) | [73.1](/filings/0001876042-25-000047.md) | [75.7](/filings/0001876042-26-000150.md) | [108](/filings/0001876042-26-000248.md) | [267](/filings/0001876042-25-000047.md) | [267](/filings/0001876042-26-000150.md) | [269](/filings/0001876042-26-000248.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.